비만세포에서 連翹 추출물의 Th2 사이토카인 발현 및 신호전달 기전 억제효과
The Suppressive Effect of Th2 Cytokines Expression and the Signal Transduction Mechanism in MC/9 Mast Cells by Forsythiae Fructus Extracts
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
ObjectivesForsythiae Fructus treatment has been used for inflammatory and allergic diseases in Korean Medicine. Nevertheless, the mechanism of action and the cellular targets are not understood well. The pathogenesis of allergicdiseases are associated with Th2 cytokines such as IL-13, MIP-1α, IL-13, IL-5, GM-CSF, IL-4, TNF-α and IL-6,which are secreted by the mast cells. This study was conducted to investigate the effects of Forsythiae Fructusextracts (FF) on Th2 cytokines expression and signal transduction in MC/9 mast cells. MethodsIn the study, MC/9 mast cells were stimulated with DNP-IgE for 24 hours and then treated separately with CsA10 ㎍/㎖ and varying doses of FF for one hour. MC/9 mast cells stimulated with DNP-IgE was the control group,a treatment with CsA was the positive control group and a treatment with varying doses FF was the experimentalgroups. The mRNA levels of IL-13, IL-5, GM-CSF, IL-4, TNF-α, IL-6 were analyzed with Real-time PCR. Thelevels of IL-13, MIP-1α were measured using enzyme-linked immunosorbent assays(ELISA). NFAT, AP-1 and NF-κB p65 were examined by Western blot analysis. Results1. FF were observed to suppress the mRNA expression of IL-13, IL-5, GM-CSF, IL-4, TNF-α, IL-6 in comparisonto DNP-IgE control group. 2. FF also has inhibited the IL-13, MIP-1α production significantly in comparison to DNP-IgE control group. 3. Western blot analysis of transduction factors involving Th2 cytokines expression has revealed a prominentdecrease of the mast cell specific transduction factors including NFAT-1, NFAT-2, c-Jun, and NF-κB p65 butc-Fos. ConclusionsIn conclusion, the anti-allergenic activities of FF may be strongly related to the regulation of transcription factorsNFAT-1, NFAT-2, c-Jun, and NF-κB p65 causing inhibition of Th2 cytokines in mast cells.
Abstract
ObjectivesForsythiae Fructus treatment has been used for inflammatory and allergic diseases in Korean Medicine. Nevertheless, the mechanism of action and the cellular targets are not understood well. The pathogenesis of allergicdiseases are associated with Th2 cytokines such as IL-13, MIP-1α, IL-13, IL-5, GM-CSF, IL-4, TNF-α and IL-6,which are secreted by the mast cells. This study was conducted to investigate the effects of Forsythiae Fructusextracts (FF) on Th2 cytokines expression and signal transduction in MC/9 mast cells. MethodsIn the study, MC/9 mast cells were stimulated with DNP-IgE for 24 hours and then treated separately with CsA10 ㎍/㎖ and varying doses of FF for one hour. MC/9 mast cells stimulated with DNP-IgE was the control group,a treatment with CsA was the positive control group and a treatment with varying doses FF was the experimentalgroups. The mRNA levels of IL-13, IL-5, GM-CSF, IL-4, TNF-α, IL-6 were analyzed with Real-time PCR. Thelevels of IL-13, MIP-1α were measured using enzyme-linked immunosorbent assays(ELISA). NFAT, AP-1 and NF-κB p65 were examined by Western blot analysis. Results1. FF were observed to suppress the mRNA expression of IL-13, IL-5, GM-CSF, IL-4, TNF-α, IL-6 in comparisonto DNP-IgE control group. 2. FF also has inhibited the IL-13, MIP-1α production significantly in comparison to DNP-IgE control group. 3. Western blot analysis of transduction factors involving Th2 cytokines expression has revealed a prominentdecrease of the mast cell specific transduction factors including NFAT-1, NFAT-2, c-Jun, and NF-κB p65 butc-Fos. ConclusionsIn conclusion, the anti-allergenic activities of FF may be strongly related to the regulation of transcription factorsNFAT-1, NFAT-2, c-Jun, and NF-κB p65 causing inhibition of Th2 cytokines in mast cells
참고문헌 (51)
- Herbology Association of Korea's Colleges of Oriental Medicine, "Textbook of herbology", pp.199~ (1991), Younglimsa
- Ju YS., "Ungok herbology", pp.494~497 (2013), Woosuk Press
- Wangang, "Benchobeiyao", pp.29~ (2012), Zhongguoyiyaokechichuban
- Quanchuncong, "Yimenzhuiyan", pp.464~ (2009), Yibang medicalbooks
- GongtingXian, "Wanbinghuichun", pp.50~82 (2007), Bubin Publishers
- Huh J., "Donguibogam", Bubin Publishers
- Kim MJ, "A literature study of atopic dermatitis for children", J Korean Orient Med, 14(2), pp.169~184 (2000)
- 민들레, "아토피 피부염 외용제에 관련된 국내 임상 및 실험 논문 고찰", 대한한방소아과학회지, 27(1), pp.36~49 (2013), 대한한방소아과학회
- Kwon OS, "The effect of Yunkyopaedosangamibang on allergic contact dermatitis : Based on the mitigation of skin damage and distributive change of mast cell on DNCB re - expasure region of mice", Dongguk J Institute Orient Med, 8(1), pp.77~91 (1999)
- Li ZX, "Investigation on antibacterial activity of forsytjia suspense vahl in vitro with Mueller-Hinton agar", Zhongguo Zhon Yoo Zhi, 25(12), pp.742~745 (2000)
- Lee EB, "Pharmacological studies on Forsythae Fructus", Kor J Pharmacogn, 19(4), pp.262~269 (1998)
- 남정범, "連翹 에탄올 추출물의 대식세포의 염증성 사이토카인 합성과 신호전달에 대한 조절", 대한본초학회지, 27(1), pp.59~64 (2012), 대한본초학회
- 김성윤, "연교 추출물의 Microglia에서 LPS에 의해 유도되는 염증매개물질 생성 억제 효과", 대한본초학회지, 23(3), pp.93~102 (2008), 대한본초학회
- 이정민, "연교(Forsythia viridissima Lindl.) 추출물이 고콜레스테롤 식이 흰쥐 간조직의 항산화계와 지질과산화에 미치는 영향", Journal of Nutrition and Health, 36(10), pp.990~996 (2003), 한국영양학회
- Rim YS, "Screening of antioxidant and antimicrobial activity in native plants", Korean J Medicinal Crop Sci, 4(8), pp.342~350 (2000)
- Lim DK, "Antioxidative activity of ethanol extract from korean medicinal plants", Korean J Food Sci Techno, 8(4), pp.342~350 (2000)
- Lue LF, "Inflammatory repertoire of alzheimer's disease and nondemented elderly microglia in vitro", Glia, 35, pp.72~79 (2001)
- Schinella GR, "Antioxidant activity of anti-inflammatory plant extracts", Life Sci, 70, pp.1023~1033 (2002)
- 윤경섭, "연교추출물의 피부 항노화 효과", KSBB Journal, 21(6), pp.444~450 (2006), 한국생물공학회
- 윤지연, "加味淸心蓮子湯이 NC", Nga mice의 아토피樣 피부염에 미치는 영향, 2007, pp.21(1), 87~116[DOI]
- 박슬기, "NC", Nga 생쥐에서 加味淸心蓮子湯의 GATA-3 조절에 의한항아토피 피부염 효과, 2009, pp.23(2), 29~50[DOI]
- 송현지, "아토피樣 피부염 NC", Nga생쥐에서 加減消毒飮의 투여가 피부염에 미치는 영향, 2009, pp.23(1), 23~35[DOI]
- Shin DG, "Effect of Sunbangpaedoktang on the cytokine secretory function of monocyte isolated and cultured from peripheral blood of AD patients", J Pediatr Korean Med, 16(1), pp.13~82 (2002)
- 김우연, "沆瀣丹이 아토피 피부염 환자 단핵세포의 Cytokine 분비능에 미치는 영향", 대한한방소아과학회지, 21(2), pp.169~186 (2007), 대한한방소아과학회
- 박용민, "아토피피부염 병태생리에 대한 최신 지견", Allergy Asthma & Respiratory Diseases, 16(3), pp.189~196 (2006), 대한 소아알레르기 호흡기학회
- Ahn HS, "Hongchangui pediatrics", pp.1142~ (2010), Miraen
- Park Y, "Moisturizers in atopic dermatitis", J Skin Barrier Research(Korean), 9(1), pp.37~40 (2007)
- Kim JW, "Atopic dermatitis at allergic and immunological aspects", J Korean Dermatol Assoc, 41(6), pp.687~689 (2003)
- Renz H, "Enhanced IL-4 production and IL-4receptor expression in atopic dermatitis and their modulation by interferon-gamma", J Invest Dermatol, 99(4), pp.403~408 (1992)
- Valent P, "Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor", kit-ligand in long-term culture, 1992, pp.80(9), 2237~2245
- Ahn SG, "Atopic dermatitis for the opening doctor", pp.13~82 (2007), Pacific Publisher Co
- Munetaka I, "A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability", Talanta, 44(7), pp.1299~1305 (1997)
- Greer FR, "Effect of early nutritional interventions on the development of atopic disease in infants and children : the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas", Pediatrics, 111, pp.608~616 (2008)
- Van der Hulst AE, "Risk of developing asthma in young children with atopic eczema; a systemic review", J Allegy Clin Immunol, 120, pp.565~569 (2007)
- Mosmann TR, "Th1 and Th2 cells; Different patterns of lymphokine secretion lead to different functional properties", Annu Rev Immunol, 7, pp.145~173 (1989)
- Foster PS, "Interleukins-4, -5, and-13 : emerging therapeutic targets in allergic disease", Pharmacol Ther, 94(3), pp.253~624 (2002)
- Gibbs BF, "Early IgE-dependent release of IL-4 and IL-13 from leukocytes is restricted to basophils : a comparison with other granulocytes and mononuclear cells", Inflamm Res, 49(1), pp.9~10 (2000)
- 김진택, "소아천식 기도염증의 비침습적 평가방법", Korean Journal of Pediatrics, 44(3), pp.334~339 (2001), 대한소아과학회
- Weber A, "Pattern analysis of human cutaneous mast cell populations by total body surface mapping", Br J Dermatol, 148(2), pp.224~228 (2003)
- Humbert M, "High-affinity IgE receptor(Fcepsiolon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma", Am J Respir Crit Care Med, 153, pp.1931~1937 (1996)
- Toru H, "Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking : enhanced IL-13 production by IL-4-primed human mast cells", J Allergy Clin Immunol, 102(3), pp.491~502 (1998)
- Matsubara M, "Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia(RBL-2H3)cells", Biochem Pharmacol, 67(7), pp.1315~1326 (2004)
- Kou X, "Arctigenin inhibits lipopolysaccharide -induced iNOS expression in RAW264.7cells through suppressing JAK-STAT signal pathway", Int Immunopharmacol, 11(8), pp.1095~1102 (2011)
- Jang HH, "Effects of arctigenin on nitric oxide production in human umbilical vein endothelial cells", pp.2010
- Ji Yun Lee, "Arctigenin, a Phenylpropanoid Dibenzylbutyrolactone Lignan, Inhibits Type I-IV Allergic Inflammation and Pro-inflammatory Enzymes", Archives of Pharmacal Research, 33(6), pp.947~957 (2010), 대한약학회
- 박지호, "Forsythiae Fructus and Its Active Component, Arctigenin, Provide Neuroprotection by Inhibiting Neuroinflammation", Biomolecules & Therapeutics, 19(4), pp.425~430 (2011), 한국응용약물학회
- 이동자, "B16 Melanoma 세포에서 Arctigenin이 Tyrosinase 활성과 Melanin 생성에 미치는 영향", 약 학 회 지, 56(6), pp.395~400 (2012), 대한약학회
- 이임선, "NFAT(nuclear factor of activated T cells) 전사인자에 대한 천연물의 저해활성", 생약학회지, 34(2), pp.150~155 (2003), 한국생약학회
- Lewin I, "Regulation of AP-1 expression and activity in antigen-stimulated mast cells : the role played by protein kinase C and the possible involvement of Fos interacting protein", Blood, 82(12), pp.3745~3751 (1993)
- D'Acquisto F, "Inhibition of Nuclear Factor Kappa B(NF-κB):An emerging theme in anti-inflammatory therapies", Mol Interv, 2(1), pp.22~35 (2002)
- Park GY, "Pro-inflammatory cytokine expression through NF-κB", IκB pathway in lung epithelial cells, 2000, pp.49(3), 332~342
